Skip to content
2000
Volume 13, Issue 9
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

An urgent need for the discovery of novel anticancer agents is required for the long term therapy of cancer. Large number of novel bio-active and potential anticancer agents are being used in clinical and pre-clinical trials. Although many heterocyclic compounds are already available commercially as anticancer agents, great efforts have been put to identify novel anticancer targets. This review provides an insight of the novel anticancer targets and molecules of the first and final stage of clinical and pre-clinical trials.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/13895575113139990061
2013-07-01
2025-10-20
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/13895575113139990061
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test